Newsletter Subject

Prenatal Maternal Distress During Pandemic Tied to Newborn Brain Development

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Thu, Jun 20, 2024 10:45 PM

Email Preheader Text

Daily Headlines Thursday, June 20, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT

[MEDPAGE TODAY]( Daily Headlines Thursday, June 20, 2024 Today's Top Stories for {NAME} [NEUROLOGY]( [Prenatal Maternal Distress During Pandemic Tied to Newborn Brain Development]( [PUBLIC HEALTH & POLICY]( [FDA Plans to Ease Requirements for Biosimilars' Interchangeable Status]( [RHEUMATOLOGY]( [Lupus Complications Reduced With Common Diabetes Drug]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Optimizing Anemia Management in Patients With Myelodysplastic Syndrome, Myelofibrosis, and Beta Thalassemia Through Shared Decision-Making]( [PRACTICE MANAGEMENT]( [Medicare Pay, Prior Auth, and More: A Q&A With the AMA's President-Elect]( [ONCOLOGY/HEMATOLOGY]( [Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [PSYCHIATRY]( [Majority of Bisexual and Transgender People Feel Lonely, Survey Shows]( CME SPOTLIGHT [Integrating Novel Bispecific Antibody Therapies Into Treatment Paradigms in Relapsed/Refractory Follicular Lymphoma]( [PSYCHIATRY]( [Only a Third of Mental Health Clinics Offer Meds for Opioid Use Disorder]( [POP MEDICINE]( [Colonoscopies at Disney World Fact-Check; The Cult of Nursing; Musk Versus ED Doc]( [MEETING COVERAGE]( [Glofitamab Regimen Improves Survival in DLBCL]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [On-Demand Mastery of the Roles of Polypharmacy, Novel Therapies, and Individualized Management of Indolent Systemic Mastocytosis (ISM)]( [DERMATOLOGY]( [Topical Agent for Hyperhidrosis Wins FDA Approval]( [PERSPECTIVES]( [AI Just Permanently Changed My Medical Practice for the Better]( [INFECTIOUS DISEASE]( ['We're Flying Blind' on H5N1: Experts See Repeat of CDC's Missteps on COVID Testing]( CME SPOTLIGHT [Expert Insight Into von Hippel-Lindau (VHL) Disease: From Symptoms and Diagnosis to Cutting-Edge Therapies and Adverse Event Management]( [MEETING COVERAGE]( [Using MRD Status to Deescalate Multiple Myeloma Therapy]( [MEETING COVERAGE]( [Study Tests BTK Inhibitor for Poorly Controlled Asthma]( [SPECIAL REPORTS]( [Man Sentenced for Defrauding Doctor; Nurse Gets Probation for Storming U.S. Capitol]( CME SPOTLIGHT [Latest Evidence for Treating Secondary AML]( [SPECIAL REPORTS]( [BMJ Paper at Center of COVID Vax Deaths Controversy Gets Expression of Concern]( [NURSING]( [Nurses in Oregon Take to the Picket Lines to Demand Better Staffing, Higher Pay]( [OPHTHALMOLOGY]( [Antibiotics May Not Be Necessary to Prevent Endophthalmitis After Cataract Surgery]( CME SPOTLIGHT [Updates to AML Classification and Treatment Paradigm]( [AAD READING ROOM]( [Crisaborole Effective Against Stasis Dermatitis]( # Weekly Survey [Is Medical Debt a Big Problem for Your Patients?]( The Biden administration [recently announced]( a plan to remove patients' medical debt from their credit scores[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-06-20&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.